Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-14-016098)

Filing Details

Accession Number:: 0001181431-14-016098
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-04-11 18:30:59
Reporting Period:: 2014-03-11

Filing Date:: 2014-04-11
Accepted Time:: 2014-04-11 18:30:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1399529	Dicerna Pharmaceuticals Inc	DRNA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1028348	Brookside Capital Partners Fund Lp	John Hancock Tower, 200 Clarendon Street Boston MA 02116		No	No	Yes	No
1056548	P L Investors Capital Brookside	John Hancock Tower, 200 Clarendon Street Boston MA 02116		No	No	Yes	No
1156175	Brookside Capital Management Llc	John Hancock Tower, 200 Clarendon Street Boston MA 02116		No	No	Yes	No
1461875	Brookside Capital Trading Fund, L.p.	John Hancock Tower, 200 Clarendon Street Boston MA 02116		No	No	Yes	No
1461876	Brookside Capital Investors Ii, L.p.	John Hancock Tower, 200 Clarendon Street Boston MA 02116		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-03-11	257,100	$38.00	2,079,900	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-11	2,900	$38.37	2,077,000	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-12	1,500	$37.77	2,075,500	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-14	50,400	$35.33	2,025,100	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-14	200,000	$35.50	1,825,100	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-17	9,301	$36.50	1,815,799	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-18	250,000	$37.75	1,565,799	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2014-03-18	14,937	$38.62	1,550,862	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

Brookside Capital Management, LLC ("BCM"). BCM is the sole general partner of Brookside Capital Investors, L.P. ("BCI"), which is the general partner of Brookside Capital Trading Fund, L.P. (the "Fund"). By virtue of these relationships, BCM and BCI may be deemed to beneficially own the securities held by the Fund. Each of BCM and BCI disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.